Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Antibodies, Monoclonal × Clear all

NCT06455072 2024-06-12

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms